Clinical Trial: A Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer

U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07241767) titled 'A Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer' on Nov. 14.

Brief Summary: Evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of FH-006 in combination with other anti-tumor treatments in lung cancer subjects, and determine the recommended dose (RP2D) and initial efficacy for phase II clinical trials.

Study Start Date: Nov. 12

Study Type: INTERVENTIONAL

Condition: Lung Cancer

Intervention: DRUG: FH-006 ; SHR-1316 ; BP102 ; Cisplatin ; Carboplatin

FH-006 ; SHR-1316 ; BP102 ; Cisplatin ; Carboplatin

DRUG: FH-006 ; SHR-1316 ; BP102

FH-...